vimarsana.com
Home
Live Updates
Fusion Antibodies completes 'difficult' restructuring proces
Fusion Antibodies completes 'difficult' restructuring proces
Fusion Antibodies completes 'difficult' restructuring process as directors are paid in shares
BELFAST-based antibody developer Fusion Antibodies has completed what is says has been a "difficult" restructuring process, which has involved a new share placing to raise funds.
Related Keywords
Belfast ,
United Kingdom ,
Adrian Kinkaid ,
Queen University ,
Fusion Antibodies ,
Stock Market ,
R Adrian Kinkaid ,
Share Placing ,
Restructuring ,
,